AR

Anjali Rajesh Giri

Active Director Director DIN 10423071
DIN 10423071 First appointment Dec 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2023
Shareholding value •••• Premium profile

About Anjali Rajesh Giri

Data last updated:

Anjali Rajesh Giri is a Director at Rvt Pharma Enterprises Private Limited (since 2023). The company operates in Pharma. Rvt Pharma Enterprises Private Limited reported revenue of ₹52.8 Lakh (FY 2025).

DIN 10423071
Primary Designation Director
Industry Pharma
First Appointment 19 Dec 2023
Oldest Company Age 2 yrs
Largest company Rvt Pharma Enterprises Private Limited · ₹52.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 Dec 20232023₹52.8 Lakh (FY 2025)Active

Directorship timeline

Open interactive timeline →
Rvt Pharma Enterprises Private Limited
Premium access

Shareholding and investment profile for Anjali Rajesh Giri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anjali Rajesh Giri

Anjali Rajesh Giri currently holds 1 directorship: Rvt Pharma Enterprises Private Limited (Director, since 19 Dec 2023, revenue ₹52.8 Lakh (FY 2025)).

Anjali Rajesh Giri was first appointed on 19 Dec 2023 as Director at Rvt Pharma Enterprises Private Limited.

The current boards of Anjali Rajesh Giri's companies include Priti Vishal Thakare (Rvt Pharma Enterprises Private Limited), Rajashri Manohar Rokade (Rvt Pharma Enterprises Private Limited), Shagufta Jahan Tanzil Ur Rahman (Rvt Pharma Enterprises Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available